ARTICLE | Clinical News
Xarelto rivaroxaban regulatory update
August 4, 2008 7:00 AM UTC
Johnson & Johnson submitted an NDA to FDA for rivaroxaban to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing hip or knee replacement surgery. ...